Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 14, Issue SUPPL. 3, 2003, Pages

  Lee, Hi Bahl ^a   Yu, Mi Ra ^a   Yang, Yanqiang ^a,b   Jiang, Zongpei ^a,b   Ha, Hunjoo ^a  

^a Soonchunhyang University   (South Korea)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSIN; ANTIOXIDANT; APOCYNIN; CATALASE; CURCUMIN; DIPHENYLIODONIUM SALT; ENZYME INHIBITOR; FIBRONECTIN; GLUCOSE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; STAT1 PROTEIN; SUPEROXIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA1; TROLOX C;

ANIMAL CELL; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ELECTRON TRANSPORT; ENZYME INHIBITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; GLOMERULUS; HUMAN; HUMAN CELL; KIDNEY DISEASE; KIDNEY TUBULE EPITHELIUM; MESANGIUM CELL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0042867408     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
2. United Kingdom Prospective Diabetes Study 33: Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and the risk of complication in patients with type 2 diabetes. Lancet 352: 837-853, 1998
3. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB: Role of high glucose-induced nuclear factor-κB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002
4. Ha H, Lee HB: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 58[Suppl 77]: S19-S25, 2000
5. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93: 536-542, 1994
6. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-β and fibronectin synthesis. Kidney Int 54: 1872-1878, 1998
7. Ayo SH, Radnik RA, Garoni JA, Glass WF II, Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136: 1339-1348, 1990
8. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D: Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59: 87-95, 2001
9. Yang Y, Ha H, Lee HB: Role of reactive oxygen species in TGF-β1-induced epithelial-mesenchymal transition [Abstract]. Nephrol Dial Transplant 18[suppl 4]: 300, 2003
10. Studer RK, Craven PA, Derubertis FR: Antioxidant inhibition of protein kinase C-signaled increase in transforming growth factor-beta in mesangial cells. Metabolism 46: 918-925, 1997
11. Ha H, Lee SH, Kim KH: Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-beta and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells. J Pharmacol Exp Ther 281: 1457-1462, 1997
12. Ha H, Yang Y, Lee HB: Mechanisms of reactive oxygen species generation in LLC-PK1 cells cultured under high glucose [Abstract]. J Am Soc Nephrol 13: 531A, 2002
13. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000
14. Fontayne A, Dang PM, Gougerot-Pocidalo MA, El-Benna J: Phosphorylation of p47phox sites by PKCα βII, δ, and η: Effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41: 7743-7750, 2002
15. Frey RS, Rahman A, Kefer JC, Minshall RD, Malik AB: PKCη regulates TNF-α-induced activation of NADPH oxidase in endothelial cells. Circ Res 17: 1012-1019, 2002
16. Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000
17. Li N-M, Shah AM: Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277: 19952-19960, 2002
18. Nishikawa T, Edelstein D Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Bee be D, Oates PJ, Hammes H-P, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three different pathways of hyperglycemic damage. Nature 404: 787-790, 2000
19. Scivittaro V, Ganz MB, Weiss MF: AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells. Am J Physiol 278: F676-F683, 2000
20. Yamagishi S-I, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M: Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells. Kidney Int 63: 464-473, 2003
21. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL: Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol 280: E685-E694, 2001
22. Lal MA, Brismar H, Eklof AC, Aperia A: Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int 61: 2006-2014, 2002
23. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54: 775-784, 1998
24. Seshiah PN, Weber DS, Rocic P, Valppu L, Tanuyama Y, Griendling KK: Angiotensin II stimulation of NAD(P)H oxidase activity: Upstream mediators. Circ Res 91: 406-413, 2002
25. Ha H, Yu MR, Choi YJ, Lee HB: Activation of protein kinase C-δ and C-ε by oxidative stress in early diabetic rat kidney. Am J Kidney Dis 38[Suppl 1]: S204-S207, 2001
26. Dunlop ME, Muggli EE: Small heat shock protein alteration provide a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney Int 57: 464-475, 2000
27. Wilmer WA, Dixon CL, Herbert C: Chronic exposure of human mesangial cells to high glucose environment activates the p38 MAPK pathway. Kidney Int 60: 858-871, 2001
28. Lee GT, Ha H, Jung M, Li HR, Hong SW, Cha BS, Lee HC, Cho DH: Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J Am Soc Nephrol 14: 709-720, 2003
29. Ha H, Yu MR, Lee GT, Lee HC, Lee HB: Reversal of extracellular signal-regulated kinase activation by lithospermate B in experimental diabetes [Abstract]. J Am Soc Nephrol 12: 836A, 2001
30. Wang X, Shaw S, Amiri F, Eaton DC, Marrero MB: Inhibition of the JAK/STAT signaling pathway prevents the high glucose-induced increase in TGF-β and fibronectin synthesis in mesangial cells. Diabetes 51: 3505-3509, 2002
31. Simon AR, Rai U, Fanburg BL, Cochran BH: Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275: C1640-C1652, 1998
32. Thannickal VJ, Fanburg BL: Reactive oxygen species in cell signaling. Am J Physiol 279: L1005-L1028, 2000
33. Utimura R, Fujihara CK, Mattar AL, Malheiros DMAC, de Lourdes Noronha I, Zatz R: Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63: 209-216, 2003
34. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Takeda SI, Takasawa K, Yoshimura M, Kida H, Kobayashi KI, Mukaida N, Naito T, Matsushima K, Yokoyama H: Upregulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58: 1492-1499, 2000
35. Weigert C, Sauer U, Brodbeck K, Pfilffer A, Haering HU, Schleicher ED: AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-β1 promoter in mesangial cells. J Am Soc Nephrol 11: 2007-2016, 2000
36. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97: 12222-12226, 2000
37. Ziyadeh FN, Hoffman BB, Iglesias-De La Cruz MC, Han DC, Hong SW, Isono M, Chen S, Mcwan T, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-β antibody in db/db mice. Proc Natl Acad Sci U S A 97: 8015-8020, 2000
38. Oldfield MD, Bach LS, Forbes JM, Nikolic-Pateerson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108: 1853-1863, 2001
39. Baricos WH, Cortez SL, Deboisblanc M, Xin S: Transforming growth factor-β is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 10: 790-795, 1999
40. Ha H, Seo J, Lee EA, Kim YS, Lee HB: Reactive oxygen species mediate upregulation of plasminogen activator inhibitor-1 secretion by mesangial cells cultured under high glucose [Abstract]. J Am Soc Nephrol 12: 836A, 2001
41. Ha H, Yu MR, Kim KH: Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 26: 944-950, 1999
42. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 50: 2114-2125, 2001